ClinicalTrials.Veeva

Menu

Comparison of 20-core Versus 12-core Prostate Biopsy Diagnostic Performance in the Detection of Prostate Cancer

P

Poitiers University Hospital

Status

Completed

Conditions

Prostate Cancer

Treatments

Procedure: prostate biopsy

Study type

Interventional

Funder types

Other

Identifiers

NCT00992615
BP20-12

Details and patient eligibility

About

The optimal number of prostate cores extracted during a prostate biopsy performed because of a suspected prostate cancer is still debated. The present consensus is to sample 12 cores. However, recent data published in the literature brought arguments in favour of a higher number, probably 20. This would have the advantages of decreasing the false negatives and the re-biopsy rate.

Sex

Male

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients older than 18
  • Patients with a PSA value between 3 et 20 ng/ml
  • Obtained informed consent
  • Patients able to comply with the study protocol
  • Patients covered by a social insurance

Exclusion criteria

  • None

Trial design

0 participants in 2 patient groups

Arm 20 cores
Experimental group
Treatment:
Procedure: prostate biopsy
arm 12 cores
Active Comparator group
Treatment:
Procedure: prostate biopsy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems